Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

2015 ◽  
Vol 20 (4) ◽  
pp. 709-722 ◽  
Author(s):  
Hiroyasu Yamshiro ◽  
Hiroji Iwata ◽  
Norikazu Masuda ◽  
Naohito Yamamoto ◽  
Reiki Nishimura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Trastuzumab Therapy

scholarly journals Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients

2015 ◽  
Vol 20 (4) ◽  
pp. 723-724
Author(s):  
Hiroyasu Yamshiro ◽  
Hiroji Iwata ◽  
Norikazu Masuda ◽  
Naohito Yamamoto ◽  
Reiki Nishimura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Trastuzumab Therapy

scholarly journals Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

Breast Cancer ◽  
2020 ◽  
Vol 27 (4) ◽  
pp. 631-641
Author(s):  
Hiroyasu Yamashiro ◽  
◽  
Hiroji Iwata ◽  
Norikazu Masuda ◽  
Naohito Yamamoto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Trastuzumab Therapy

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

2015 ◽  
Vol 11 (10) ◽  
pp. 1493-1500 ◽  
Author(s):  
G Mustacchi ◽  
F Puglisi ◽  
AM Molino ◽  
D Crivellari ◽  
C Ghiotto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Adjuvant Trastuzumab

Adjuvant chemotherapy for HER2-positive early breast cancer patients without perioperative radiotherapy in trastuzumab era.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e12573-e12573
Author(s):  
Kazuki Nozawa ◽  
Keiji Sugiyama ◽  
Kazuhiro Shiraishi ◽  
Yoriko Funahashi ◽  
Yoshihito Kogure ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive

Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients

2020 ◽  
Vol 20 (1) ◽  
pp. e89-e98 ◽  
Author(s):  
Luca Cantini ◽  
Mirco Pistelli ◽  
Filippo Merloni ◽  
Andrea Fontana ◽  
Ilaria Bertolini ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Cancer Patients ◽  
Body Mass ◽  
Early Breast Cancer ◽  
Hormone Receptor ◽  
Recurrence Risk ◽  
Hormone Receptor Status ◽  
Breast Cancer Patients ◽  
Her2 Positive
Sign in / Sign up

Export Citation Format

Share Document